ANIP
ANI Pharmaceuticals Inc
78.90$
+3.6%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +36.4% | +68.5% | +37.5% | +14.0% | +2.5% | +0.9% | +3.7% | +46.4% | +53.9% | +26.2% | +43.8% | |
| – | +10.6% | +284.3% | +62.0% | -7.6% | -13.5% | +38.0% | +15.4% | +37.9% | +30.8% | +37.8% | +72.9% | |
| – | +43.0% | +25.5% | +22.5% | +31.4% | +11.5% | -15.4% | -4.8% | +53.7% | +71.9% | +19.3% | +23.7% | |
| – | +7.3% | +1.1% | +212.1% | +69.7% | +28.7% | -19.2% | -28.9% | +96.3% | +53.6% | +30.0% | +15.9% | |
| – | +18.0% | +31.5% | +13.5% | +39.5% | +26.7% | +16.4% | +29.7% | +51.6% | +17.7% | +66.0% | +27.3% | |
| – | +26.3% | +71.6% | +29.2% | +35.9% | +36.3% | +8.1% | +13.1% | +37.1% | +21.3% | +40.7% | +1.6% | |
| – | +63.5% | -38.6% | +41.1% | +24.8% | -53.8% | -198.0% | – | – | – | -98.8% | +13,809.2% | |
| – | +1,298.7% | +2.9% | +6.3% | +22.6% | -12.1% | -27.1% | +26.1% | +135.3% | -4.0% | -34.7% | +14.0% | |
| – | +12.1% | -60.1% | +88.4% | +22.6% | -84.3% | -922.4% | – | – | – | -211.8% | – | |
| – | – | -25.4% | +267.3% | -73.8% | -164.5% | – | – | – | – | -437.6% | – | |
| – | -46.5% | -74.4% | -127.4% | – | -60.7% | -470.0% | – | – | – | -198.6% | – | |
| – | +64.9% | +42.0% | +1.5% | +20.9% | -12.1% | -53.7% | -88.9% | +703.6% | +325.7% | -40.8% | +228.4% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.